Danaher Management
Management criteria checks 3/4
Danaher's CEO is Rainer Blair, appointed in Sep 2020, has a tenure of 4.25 years. total yearly compensation is $20.90M, comprised of 6.2% salary and 93.8% bonuses, including company stock and options. directly owns 0.014% of the company’s shares, worth $22.40M. The average tenure of the management team and the board of directors is 5.9 years and 14.6 years respectively.
Key information
Rainer Blair
Chief executive officer
US$20.9m
Total compensation
| CEO salary percentage | 6.2% |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.01% |
| Management average tenure | 5.9yrs |
| Board average tenure | 14.6yrs |
Recent management updates
Recent updates
Danaher: A Resilient And Solid Company With Growth Potential
Dec 10Danaher (NYSE:DHR) Seems To Use Debt Quite Sensibly
Dec 08
Understanding Danaher's Cautiousness
Oct 25Is There Now An Opportunity In Danaher Corporation (NYSE:DHR)?
Sep 28Danaher Q3 Preview: Market Share Gains In Molecular Testing
Sep 25Is Danaher Corporation (NYSE:DHR) Trading At A 32% Discount?
Sep 12Here's Why Danaher (NYSE:DHR) Can Manage Its Debt Responsibly
Aug 28Danaher: Lofty Price, Bright Future
Aug 22Danaher Corporation's (NYSE:DHR) Price In Tune With Earnings
Aug 13Danaher: Valuation Now Too High Even Compared To Own High Standards
Jul 16What Is Danaher Corporation's (NYSE:DHR) Share Price Doing?
Jun 23Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum
Jun 20Is Danaher Corporation (NYSE:DHR) Worth US$263 Based On Its Intrinsic Value?
Jun 05Is Danaher (NYSE:DHR) A Risky Investment?
May 21It's Unlikely That Danaher Corporation's (NYSE:DHR) CEO Will See A Huge Pay Rise This Year
May 01Value Vs. Growth? Danaher Says Why Not Both?
Apr 25Danaher: All In On Life Sciences, And Market Update
Mar 27Is Now An Opportune Moment To Examine Danaher Corporation (NYSE:DHR)?
Mar 11Danaher Corporation's (NYSE:DHR) Price Is Out Of Tune With Earnings
Feb 10Bull Case Confirmed: Danaher Is Still One Of The Best Stocks To Buy Long-Term
Jan 30Is Danaher (NYSE:DHR) Using Too Much Debt?
Jan 12My Top 2024 Stock Pick: Danaher
Dec 27Danaher: Poised For Long-Term Growth Despite Near-Term Hurdles
Nov 26RGA Investment Advisors - Danaher: Purity In The Crown Jewel Of Bioprocessing
Nov 19Why Danaher Is One Of My Favorite Long-Term Investments
Oct 26Danaher: Short-Term Headwinds, But Long-Term Tailwinds
Oct 17Should Danaher Investors Sell New Veralto Shares?
Oct 02Danaher: A Lost Year
Aug 30Third Point - Danaher: Don't Be Surprised If Growth Rate Moves To Low Teens
Aug 02Danaher: A Compounding Icon At A Fair Price
Jul 25Danaher: Seizing The Buying Opportunity In A Temporary Bioprocessing Slump
Jun 22CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 27 2024 | n/a | n/a | US$4b |
| Jun 28 2024 | n/a | n/a | US$4b |
| Mar 29 2024 | n/a | n/a | US$4b |
| Dec 31 2023 | US$21m | US$1m | US$4b |
| Sep 29 2023 | n/a | n/a | US$4b |
| Jun 30 2023 | n/a | n/a | US$5b |
| Mar 31 2023 | n/a | n/a | US$6b |
| Dec 31 2022 | US$20m | US$1m | US$6b |
| Sep 30 2022 | n/a | n/a | US$7b |
| Jul 01 2022 | n/a | n/a | US$6b |
| Apr 01 2022 | n/a | n/a | US$6b |
| Dec 31 2021 | US$17m | US$1m | US$5b |
| Oct 01 2021 | n/a | n/a | US$6b |
| Jul 02 2021 | n/a | n/a | US$5b |
| Apr 02 2021 | n/a | n/a | US$5b |
| Dec 31 2020 | US$10m | US$949k | US$4b |
| Oct 02 2020 | n/a | n/a | US$3b |
| Jul 03 2020 | n/a | n/a | US$3b |
| Apr 03 2020 | n/a | n/a | US$3b |
| Dec 31 2019 | US$7m | US$840k | US$2b |
| Sep 27 2019 | n/a | n/a | US$2b |
| Jun 28 2019 | n/a | n/a | US$2b |
| Mar 29 2019 | n/a | n/a | US$2b |
| Dec 31 2018 | US$5m | US$700k | US$2b |
| Sep 28 2018 | n/a | n/a | US$3b |
| Jun 29 2018 | n/a | n/a | US$3b |
| Mar 30 2018 | n/a | n/a | US$3b |
| Dec 31 2017 | US$4m | US$625k | US$2b |
Compensation vs Market: Rainer's total compensation ($USD20.90M) is above average for companies of similar size in the US market ($USD12.85M).
Compensation vs Earnings: Rainer's compensation has been consistent with company performance over the past year.
CEO
Rainer Blair (60 yo)
4.3yrs
Tenure
US$20,903,282
Compensation
Mr. Rainer M. Blair serves as an Independent Non-Executive Director at Nestlé S.A. since April 20, 2023. He serves as President, Chief Executive Officer and Director at Danaher Corporation since September...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman | 41.9yrs | no data | 6.02% $ 9.9b | |
| President | 4.3yrs | US$20.90m | 0.014% $ 22.4m | |
| Co-Founder & Director | 41.9yrs | no data | 4.86% $ 8.0b | |
| CFO & Executive VP | 5.9yrs | US$7.50m | 0.0055% $ 9.0m | |
| Senior VP & Chief Science Officer | 4yrs | US$7.20m | 0.00037% $ 610.8k | |
| Senior Vice President of Human Resources | 2.7yrs | US$5.25m | 0.00015% $ 247.6k | |
| VP & Chief Accounting Officer | 2.9yrs | no data | 0.00082% $ 1.4m | |
| Vice President of Investor Relations | no data | no data | no data | |
| Senior VP | 8.9yrs | US$3.56m | 0.0028% $ 4.6m | |
| Senior Vice President of Corporate Development | 14.8yrs | no data | 0.0021% $ 3.5m | |
| Senior Vice President of Strategic Development | 10.6yrs | no data | 0.0067% $ 11.0m | |
| Executive VP of Biotechnology Group & CEO of Cytiva | less than a year | no data | 0.0020% $ 3.3m |
5.9yrs
Average Tenure
57yo
Average Age
Experienced Management: DHR's management team is seasoned and experienced (5.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman | 41.9yrs | no data | 6.02% $ 9.9b | |
| President | 4.3yrs | US$20.90m | 0.014% $ 22.4m | |
| Co-Founder & Director | 41.9yrs | no data | 4.86% $ 8.0b | |
| Independent Director | 25.9yrs | US$338.13k | 0.011% $ 18.6m | |
| Independent Director | 21.4yrs | US$351.13k | 0.0054% $ 8.9m | |
| Independent Director | 15.9yrs | US$338.13k | 0.0024% $ 3.9m | |
| Independent Director | 7.8yrs | US$318.13k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.7yrs | no data | no data | |
| Lead Independent Director | 19yrs | US$382.13k | 0.0057% $ 9.4m | |
| Member of Scientific Advisory Board | 3.7yrs | no data | no data | |
| Independent Director | 13.3yrs | US$318.13k | 0% $ 0 | |
| Independent Director | 5.1yrs | US$318.13k | 0% $ 0 |
14.6yrs
Average Tenure
64yo
Average Age
Experienced Board: DHR's board of directors are seasoned and experienced ( 14.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 10:57 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/27 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Danaher Corporation is covered by 54 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| John Eade | Argus Research Company |
| Catherine Ramsey Schulte | Baird |
| Ishan Majumdar | Baptista Research |